DRI Healthcare Trust T.DHT.UN

roundup

[Possibleidiot01]

• DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Stifel Nicolaus from C$20.00 to C$21.00. They now have a "buy" rating on the stock. This represents a 47.6% upside from the current price of C$14.23.
•  
• DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Scotiabank from C$22.00 to C$24.00. They now have an "outperform" rating on the stock. This represents a 68.7% upside from the current price of C$14.23.
•  
• DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at CIBC from C$18.00 to C$19.00. They now have an "outperform" rating on the stock. This represents a 33.5% upside from the current price of C$14.23.
•  
• DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at Raymond James from C$21.00 to C$22.00. They now have an "outperform" rating on the stock. This represents a 54.6% upside from the current price of C$14.23.
•  
• DRI Healthcare Trust (TSE:DHT.UN) had its price target raised by analysts at National Bankshares, Inc. from C$18.50 to C$22.00. They now have an "outperform" rating on the stock. This represents a 54.6% upside from the current price of C$14.23.

[HermannHaller]

From Scotia:  DRI Healthcare Trust DHT.U-T: US$10.24 Target: US$24.00 Old: US$22.00 Rating: Sector Outperform Out-year Revenue Runway Enhanced; Lifting Target to $24 OUR TAKE: Positive. Lifting the cap and expanding royalty interest in sales of pipeline drug, Omidria, is very favorable to our model and significantly mitigates royalty growth concerns beyond 2026 that the trust had